The Blood-brain barrier in normal conditions and pathological conditions

被引：0
|
作者：
Stern, L.
机构：
来源：
SCHWEIZER ARCHIV FUR NEUROLOGIE UND PSYCHIATRIE | 1923年 / 13卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
O1 [数学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 0701 ; 070101 ;
摘要：
引用
下载
收藏
页码：604 / 616
页数：13
相关论文
共 50 条
  • [1] The blood-brain barrier under normal and pathological conditions
    Paulson, OB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S1 - S1
  • [2] BLOOD-BRAIN BARRIER TO PROTEINS UNDER NORMAL AND PATHOLOGICAL CONDITIONS
    BRIGHTMA.MW
    KLATZO, I
    OLSSON, Y
    REESE, TS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1970, 10 (03) : 215 - &
  • [3] Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions
    Ueno, Masaki
    Chiba, Yoichi
    Murakami, Ryuta
    Matsumoto, Koichi
    Kawauchi, Machi
    Fujihara, Ryuji
    BRAIN TUMOR PATHOLOGY, 2016, 33 (02) : 89 - 96
  • [4] A Review of Mathematics Determining Solute Uptake at the Blood-Brain Barrier in Normal and Pathological Conditions
    Sprowls, Samuel A.
    Saralkar, Pushkar
    Arsiwala, Tasneem
    Adkins, Christopher E.
    Blethen, Kathryn E.
    Pizzuti, Vincenzo J.
    Shah, Neal
    Fladeland, Ross
    Lockman, Paul R.
    PHARMACEUTICS, 2021, 13 (05)
  • [5] Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditions
    Masaki Ueno
    Yoichi Chiba
    Ryuta Murakami
    Koichi Matsumoto
    Machi Kawauchi
    Ryuji Fujihara
    Brain Tumor Pathology, 2016, 33 : 89 - 96
  • [6] Pharmacological Modulation of Blood-Brain Barrier Permeability by Kinin Analogs in Normal and Pathologic Conditions
    Sikpa, Dina
    Whittingstall, Lisa
    Savard, Martin
    Lebel, Rejean
    Cote, Jerome
    McManus, Stephen
    Chemtob, Sylvain
    Fortin, David
    Lepage, Martin
    Gobeil, Fernand
    PHARMACEUTICALS, 2020, 13 (10) : 1 - 20
  • [7] Brain pericyte-derived soluble factors induce the blood-brain barrier dysfunction under pathological conditions
    Dohgu, Shinya
    Takata, Fuyuko
    Matsumoto, Junichi
    Machida, Takashi
    Takahashi, Hiroyuki
    Yamauchi, Atsushi
    Kataoka, Yasufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 25P - 25P
  • [8] Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions
    Ljubimova, Julia Y.
    Holler, Eggehard
    Black, Keith L.
    Ljubimov, Alexander, V
    NANOMEDICINE, 2024,
  • [9] Neuroinflammatory conditions may disrupt the normal function of adrenomedullin (ADM) at the blood-brain barrier (BBB)
    Liverani, E
    Woods, A
    Bolton, C
    Paul, C
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 167 - 167
  • [10] Pathological changes of the blood-brain barrier in dementias
    Popescu, B. O.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 250 - 250
12345